#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Ken Micciche Email
Director Business Development . Pressure BioSciences
Medford, MA
Locationk********@pressurebiosciences.com
Primary EmailHow to contact Ken Micciche
Join and see Ken's contact info for free!Current Roles
Employees:
26Revenue:
$3.5MAbout
Following the sale of substantially all the assets and selected liabilities of its BBI Diagnostics and BBI Biotech Divisions to SeraCare Life Sciences, Inc. on September 14, 2004, Boston Biomedica, Inc. changed its name to Pressure BioSciences, Inc (PBI). PBI is a publicly traded, early-stage company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 4 foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification. PBI owns a 30% passive investment in Source Scientific, LLC, an instrumentation company that develops and manufactures PBI\'s PCT equipment, as well as a passive investment of approximately 1 million shares in VI Technologies, an antiviral drug discovery and development company.Pressure BioSciences Address
200 Boston AvenueMedford, MA
United States